{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T11:34:13Z","timestamp":1793705653100,"version":"4.5.1"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T00:00:00Z","timestamp":1699401600000},"content-version":"vor","delay-in-days":7,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Immunological Methods"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.jim.2023.113568","type":"journal-article","created":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T19:16:06Z","timestamp":1695496566000},"page":"113568","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Standardization, validation, and comparative evaluation of a faster and high-performance test for quantification of yellow fever neutralizing antibodies"],"prefix":"10.1016","volume":"522","author":[{"given":"Marisol","family":"Sim\u00f5es","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie Almeida","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly Ara\u00fajo","family":"L\u00facio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renan","family":"de Oliveira Vieira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waleska Dias","family":"Schwarcz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila Maria Barbosa","family":"de Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz Antonio Bastos","family":"Camacho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jim.2023.113568_bb0005","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1742-5573-1-6","article-title":"WINPEPI (PEPI-for-windows): computer programs for epidemiologists","volume":"1","author":"Abramson","year":"2004","journal-title":"Epidemiol. Perspect. Innov."},{"key":"10.1016\/j.jim.2023.113568_bb0010","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1093\/infdis\/jiz379","article-title":"Yellow fever vaccine: the conundrum of 2 doses, one dose, or one-fifth dose to induce and maintain protective immunity","volume":"221","author":"Barrett","year":"2020","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jim.2023.113568_bb0015","series-title":"Bioanalytical Method Validation Guidance for Industry","year":"2018"},{"key":"10.1016\/j.jim.2023.113568_bb0020","doi-asserted-by":"crossref","first-page":"5129","DOI":"10.1016\/j.vaccine.2019.05.048","article-title":"Collaborative group for studies on yellow fever vaccines. Duration of immunity in recipients of two doses of 17DD yellow fever vaccine","volume":"37","author":"Camacho","year":"2019","journal-title":"Vaccine."},{"key":"10.1016\/j.jim.2023.113568_bb0025","first-page":"25","article-title":"Improvement in throughput and accuracy of neutralization assay results by the automation of image acquisition and analysis","author":"de Lima","year":"2020","journal-title":"BJSTR"},{"key":"10.1016\/j.jim.2023.113568_bb0030","first-page":"113","article-title":"A simple micro-culture method for the study of group B arboviruses","volume":"40","author":"De Madrid","year":"1969","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.jim.2023.113568_bb0035","series-title":"Emergence of Human Arboviral Diseases in the Americas, 2000\u20132016. Vector-Borne and Zoonotic Diseases","author":"F.C V, H C","year":"2016"},{"key":"10.1016\/j.jim.2023.113568_bb0040","doi-asserted-by":"crossref","first-page":"8236","DOI":"10.1016\/j.vaccine.2010.10.070","article-title":"WHO working group on technical specifications for manufacture and evaluation of yellow fever vaccines, Geneva, Switzerland, 13\u201314 may 2009","volume":"28","author":"Ferguson","year":"2010","journal-title":"Vaccine."},{"key":"10.1016\/j.jim.2023.113568_bb0045","doi-asserted-by":"crossref","first-page":"4761","DOI":"10.1128\/JVI.78.9.4761-4775.2004","article-title":"Safety and efficacy of chimeric yellow fever-dengue virus tetravalent vaccine formulations in nonhuman primates","volume":"78","author":"Guirakhoo","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.jim.2023.113568_bb0050","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S0035-9203(97)90050-X","article-title":"The micro-focus reduction neutralization test for determining dengue and Japanese encephalitis neutralizing antibodies in volunteers vaccinated against dengue","volume":"91","author":"Jirakanjanakit","year":"1997","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.jim.2023.113568_bb0055","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/S1286-4579(02)01647-7","article-title":"Reactivity of serum samples from patients with a flavivirus infection measured by immunofluorescence assay and ELISA","volume":"4","author":"Koraka","year":"2002","journal-title":"Microbes Infect."},{"key":"10.1016\/j.jim.2023.113568_bb0060","first-page":"243","article-title":"International collaborative assay of the international reference preparation of anti-yellow-fever serum","volume":"33","author":"Krag","year":"1965","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.jim.2023.113568_bb0065","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.tvjl.2012.08.019","article-title":"Review of diagnostic plaque reduction neutralization tests for flavivirus infection","volume":"195","author":"Maeda","year":"2013","journal-title":"Vet. J."},{"key":"10.1016\/j.jim.2023.113568_bb0070","doi-asserted-by":"crossref","first-page":"879","DOI":"10.4161\/hv.22982","article-title":"17DD yellow fever vaccine: a double blind, randomized clinical trial of immunogenicity and safety on a dose-response study","volume":"9","author":"Martins","year":"2013","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.jim.2023.113568_bb0075","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.omtm.2019.07.007","article-title":"Integration of fluorescence detection and image-based automated counting increases speed, sensitivity, and robustness of plaque assays","volume":"14","author":"Masci","year":"2019","journal-title":"Mol. Ther. Methods Clin. Developm."},{"key":"10.1016\/j.jim.2023.113568_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0177882","article-title":"Screening test for neutralizing antibodies against yellow fever virus, based on a flavivirus pseudotype","volume":"12","author":"Mercier-Delarue","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jim.2023.113568_bb0085","author":"Minist\u00e9rio da Sa\u00fade"},{"key":"10.1016\/j.jim.2023.113568_bb0090","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jcv.2014.08.030","article-title":"Yellow fever","volume":"64","author":"Monath","year":"2015","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.jim.2023.113568_bb0095","series-title":"Vaccines","first-page":"870","article-title":"Yellow fever vaccine. 6th ed","author":"Monath","year":"2013"},{"key":"10.1016\/j.jim.2023.113568_bb0100","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJMp1702172","article-title":"Yellow fever - once again on the radar screen in the Americas","volume":"376","author":"Paules","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jim.2023.113568_bb0105","doi-asserted-by":"crossref","first-page":"52","DOI":"10.4236\/ajmb.2019.92005","article-title":"Modification of periodate oxidation method to produce HRP-IgG conjugate and test its stability overtime","volume":"09","author":"Pavliuchenko","year":"2019","journal-title":"AJMB."},{"key":"10.1016\/j.jim.2023.113568_bb0110","doi-asserted-by":"crossref","first-page":"113979","DOI":"10.1016\/j.jviromet.2020.113979","article-title":"High-throughput viral microneutralization method for feline coronavirus using image cytometry","volume":"286","author":"Pearson","year":"2020","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.jim.2023.113568_bb0115","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1016\/j.vaccine.2015.03.077","article-title":"An inactivated yellow fever 17DD vaccine cultivated in Vero cell cultures","volume":"33","author":"Pereira","year":"2015","journal-title":"Vaccine."},{"key":"10.1016\/j.jim.2023.113568_bb0120","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.chom.2008.08.004","article-title":"Structural insights into the mechanisms of antibody-mediated neutralization of flavivirus infection: implications for vaccine development","volume":"4","author":"Pierson","year":"2008","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jim.2023.113568_bb0125","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/0035-9203(59)90021-5","article-title":"A plaque technique for the titration of yellow fever virus and antisera","volume":"53","author":"Porterfield","year":"1959","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.jim.2023.113568_bb0130","doi-asserted-by":"crossref","first-page":"115","DOI":"10.4269\/ajtmh.2008.79.115","article-title":"Comparative evaluation of three assays for measurement of dengue virus neutralizing antibodies","volume":"79","author":"Putnak","year":"2008","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.jim.2023.113568_bb0135","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1186\/1471-2334-12-233","article-title":"Variation in dengue virus plaque reduction neutralization testing: systematic review and pooled analysis","volume":"12","author":"Rainwater-Lovett","year":"2012","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.jim.2023.113568_bb0140","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.02548-21","article-title":"A high-throughput yellow fever neutralization assay. Ludert JE, editor","volume":"10","author":"Rasulova","year":"2022","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.jim.2023.113568_bb0145","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.vaccine.2021.12.029","article-title":"Exploratory study of humoral and cellular immunity to 17DD yellow fever vaccination in children and adults residents of areas without circulation of yellow fever virus","volume":"40","author":"Reis","year":"2022","journal-title":"Vaccine."},{"key":"10.1016\/j.jim.2023.113568_bb0150","doi-asserted-by":"crossref","first-page":"4442","DOI":"10.1016\/j.vaccine.2005.03.042","article-title":"An evaluation of dengue type-2 inactivated, recombinant subunit, and live-attenuated vaccine candidates in the rhesus macaque model","volume":"23","author":"Robert Putnak","year":"2005","journal-title":"Vaccine."},{"key":"10.1016\/j.jim.2023.113568_bb0155","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1089\/vim.2008.0007","article-title":"Guidelines for plaque-reduction neutralization testing of human antibodies to dengue viruses","volume":"21","author":"Roehrig","year":"2008","journal-title":"Viral Immunol."},{"key":"10.1016\/j.jim.2023.113568_bb0160","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jim.2014.02.013","article-title":"Optimization and validation of a neutralizing antibody assay for HIV-1 in A3R5 cells","volume":"409","author":"Sarzotti-Kelsoe","year":"2014","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jim.2023.113568_bb0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0262149","article-title":"FluoRNT: a robust, efficient assay for the detection of neutralising antibodies against yellow fever virus 17D. Roques P, editor","volume":"17","author":"Scheck","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.jim.2023.113568_bb0170","doi-asserted-by":"crossref","DOI":"10.1128\/CVI.00225-17","article-title":"Development of a high-throughput respiratory syncytial virus fluorescent focus-based microneutralization assay. Wilkins PP, editor","volume":"24","author":"Shambaugh","year":"2017","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.jim.2023.113568_bb0175","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/S1473-3099(17)30419-X","article-title":"Global yellow fever vaccination coverage from 1970 to 2016: an adjusted retrospective analysis","volume":"17","author":"Shearer","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.jim.2023.113568_bb0180","article-title":"Evaluation of accuracy and reliability of the plaque reduction neutralization test (micro-PRNT) in detection of yellow fever virus antibodies","volume":"40","author":"Sim\u00f5es","year":"2012","journal-title":"Biol. J. Int. Assoc. Biol. Stand."},{"key":"10.1016\/j.jim.2023.113568_bb0185","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/0003-2697(85)90442-7","article-title":"Measurement of protein using bicinchoninic acid","volume":"150","author":"Smith","year":"1985","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.jim.2023.113568_bb0190","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/jmp.12501","article-title":"Safety and immunogenicity of 17DD attenuated yellow fever vaccine in howler monkeys (Alouatta spp.)","volume":"50","author":"Tavares da Silva Fernandes","year":"2021","journal-title":"J. Med. Primatol."},{"key":"10.1016\/j.jim.2023.113568_bb0195","doi-asserted-by":"crossref","first-page":"962","DOI":"10.4269\/ajtmh.12-0461","article-title":"Optimization and validation of a plaque reduction neutralization test for the detection of neutralizing antibodies to four serotypes of dengue virus used in support of dengue vaccine development","volume":"88","author":"Timiryasova","year":"2013","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.jim.2023.113568_bb0200","doi-asserted-by":"crossref","first-page":"420","DOI":"10.4269\/ajtmh.16-0293","article-title":"Plant-produced subunit vaccine candidates against yellow fever induce virus neutralizing antibodies and confer protection against viral challenge in animal models","volume":"98","author":"Tottey","year":"2018","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.jim.2023.113568_bb0205","article-title":"Development of a rapid focus reduction neutralization test assay for measuring SARS-CoV-2 neutralizing antibodies","volume":"131","author":"Vanderheiden","year":"2020","journal-title":"Curr. Protoc. Immunol."},{"key":"10.1016\/j.jim.2023.113568_bb0210","doi-asserted-by":"crossref","DOI":"10.3390\/v9040077","article-title":"T cell-mediated immunity towards yellow fever virus and useful animal models","volume":"9","author":"Watson","year":"2017","journal-title":"Viruses."},{"key":"10.1016\/j.jim.2023.113568_bb0215","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.4269\/ajtmh.17-0948","article-title":"Virus reduction neutralization test: a single-cell imaging high-throughput virus neutralization assay for dengue","volume":"99","author":"Whiteman","year":"2018","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.jim.2023.113568_bb0220","first-page":"713","article-title":"17D yellow fever vaccine elicits comparable long-term immune responses in healthy individuals and immune-compromised patients","volume":"72","author":"Wieten","year":"2016","journal-title":"J. Inf. Secur."},{"key":"10.1016\/j.jim.2023.113568_bb0225","first-page":"193","article-title":"Eliminate yellow fever epidemics (EYE): a global strategy, 2017\u20132026","volume":"16","author":"World Health Organization","year":"2017","journal-title":"Wkly Epidemiol. Rec."},{"key":"10.1016\/j.jim.2023.113568_bb0230","author":"Yellow Fever - African Region (AFRO)"}],"container-title":["Journal of Immunological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175923001503?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175923001503?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T21:28:23Z","timestamp":1762205303000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022175923001503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":46,"alternative-id":["S0022175923001503"],"URL":"https:\/\/doi.org\/10.1016\/j.jim.2023.113568","relation":{},"ISSN":["0022-1759"],"issn-type":[{"value":"0022-1759","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Standardization, validation, and comparative evaluation of a faster and high-performance test for quantification of yellow fever neutralizing antibodies","name":"articletitle","label":"Article Title"},{"value":"Journal of Immunological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jim.2023.113568","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"113568"}}